The company said it held its June 27, 2024 Annual Meeting of Shareholders. As of the close of business on April 30, 2024, the record date, there were 727,594,870 common shares issued and outstanding.

1. 01

   The company said it held its June 27, 2024 Annual Meeting of Shareholders. As of the close of business on April 30, 2024, the record date, there were 727,594,870 common shares issued and outstanding.

2. 02

   The company said shareholders elected 11 directors to serve until the annual meeting in 2025 or until their successors are elected and qualified. For example, Karen M. Hoguet received 563,558,844 votes for and 6,092,356 votes against, and W. Rodney McMullen received 525,875,276 votes for and 43,889,043 votes against.

3. 03

   The company said shareholders approved executive compensation on an advisory basis, with 518,273,327 votes for and 49,641,585 votes against. The selection of PricewaterhouseCoopers LLP as independent auditor for fiscal 2024 was also approved.

4. 04

   The company said all 4 shareholder proposals were rejected. The proposal for a report on public health costs from the sale of tobacco products received 64,117,589 votes for and 499,568,269 votes against, and the living wage policy proposal received 94,120,669 votes for and 472,435,303 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.